Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-29

FDA Approved: BUDESONIDE INHALATION — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Budesonide Inhalation from Lupin Pharmaceuticals, Inc., approving changes to the approved generic inhalation product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Inhalation (Budesonide)

Snippet

SUPPL AP for BUDESONIDE INHALATION (BUDESONIDE INHALATION)